News
Project news, updates, and announcements.
iThera Medical reports initiation of fifth clinical site in EUPHORIA study for the non-invasive assessment of IBD
Medical device company iThera Medical, our coordinator, announces that the fifth site has been initiated for the ongoing clinical study in the EUPHORIA project that aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD).
The EUPHORIA (Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities) project aims to assess the ability of MSOT to measure disease activity in patients with IBD. Clinical validation of the diagnostic performance of the MSOT Acuity Echo investigational device is underway in a multicenter international study, with the I.R.C.C.S. San Raffaele Hospital (HSR) in Milan now added as the latest initiated site and the second site in Italy.
The initiation of new study sites will allow for faster patient recruitment to acquire data necessary for the clinical validation of the MSOT technology in the application of disease monitoring in IBD. Furthermore, iThera Medical will use the feedback from the various patient and investigator groups to guide the ongoing development of the MSOT technology to best benefit doctors and their patients.
Dr Mariangela Allocca – a leading physician at HSR’s Department of Gastroenterology and Gastrointestinal Endoscopy as well as EUPHORIA’s principal investigator at the Milan study site – comments on the site’s participation in EUPHORIA: “We are very excited about the initiation of HSR, and we hope to strongly contribute to the ongoing clinical validation for the use of […]
iThera produces EUPHORIA clinical study management video
EUPHORIA Coordinator iThera Medical have released a new video to showcase the processes behind managing a multi-centre international clinical study to measure inflammation using their MSOT technologies. The video features Claudia Jendrewski who takes us through the planning stages of preparation for the EUPHORIA clinical study protocol and recruitment processes. Watch it here.
Special thanks to Katherine Erlich and Jenni Martin-Krüger at iThera Medical for their work on the film.
World IBD Day 2022- the EUPHORIA message
Our 2022 social media campaign on May 19th, #WorldIBDDay includes the messages above and below.
Endoscopy is frequently used to monitor IBD, inflammatory bowel disease but can be uncomfortable and expensive. New research and technologies are needed to develop accurate, non-invasive alternatives.The EU-funded EUPHORIA study is doing just that. In EUPHORIA, hospitals in Germany and Italy are exploring the ability of iThera Medical’s MSOT technology to detect and measure inflammatory activity in people with IBD, using a non-invasive scan.We hope that in the future, MSOT will be able to improve the patient experience and offer a non-invasive alternative for monitoring IBD.
Coordinator iThera Medical leads €1.6m project to develop machine learning-assisted optoacoustic imaging of neuromuscular disease
Congratulations to our coordinators iThera Medical who announced the kickoff of the technology innovation project SMART-3D funded by the Bavarian Research Foundation, www.forschungsstiftung.de. Commencing on May 1st, 2022, the new project aims to develop a novel, innovative approach to monitoring neuromuscular disease in pediatric patients through the company’s proprietary optoacoustic imaging technology and next-generation 3D image reconstruction assisted by machine learning.
Read the official press release here.
The EUPHORIA study highlighted in German IBD patient advocacy magazine, Bauchredner
The Deutsche Morbus Crohn’s/Colitis Ulcerosa Vereinigung, or DCCV (https://www.dccv.de/) highlighted the EUPHORIA study in their February 2021 publication, Bauchredner. The five-page article can be downloaded here, or read in the images below.
The German Crohn’s Disease/Ulcerative Colitis Association (DCCV) eV is the patient advocacy association for over 400,000 people with chronic inflammatory bowel disease ( IBD ) in Germany. Founded in 1982, the DCCV is organized by those affected by IBD and is one of the largest patient associations in Germany.
We wish to thank the writers and editors of Bauchredner for featuring EUPHORIA.
iThera presents at EPIC Meeting on Laser, Optics and Sensors for Medical Devices
Photonics is a key enabling technology to understand diseases, get a better diagnosis and achieve a better therapy.
The EPIC Meeting on Laser, Optics and Sensors for Medical Devices at Laser World of Photonics will take place on April 28th, 2022 in Munich. The principal aim of this meeting is to discuss the current demands, solutions and concepts for medical instrumentation and devices.
Ronald Sroka, Technical University of Munich, Rene Dorniede of Lisa Laser and Christian Wiest CEO of iThera Medical GmbH discuss the requirements, solutions and concepts for medical instrumentation and devices envisioning photonic solutions for the concrete needs of physicians. Christian’s talk is titled ‘Translating Optoacoustic Imaging – the Long Journey from Preclinical Research into Clinical Routine’
When: Thursday, 28 April 2022, 10:00 – 12:00 CEST
Where: Conference room B61, Hall B6, Messe Munich
To register and more information: https://epic-assoc.com/events/epic-meeting-on-laser-optics-and-detectors-for-medical-devices-at-laser-world-of-photonics/
iThera Medical exhibits EUPHORIA research at EMIM 2022
Last week iThera Medical, EUPHORIA’s coordinators, exhibited at the 17th European Molecular Imaging Meeting, EMIM 2022. Partners at iThera discussed the EUPHORIA clinical study with optoacoustic imaging users working with models and patients with inflammatory bowel disease (IBD). The meeting was hosted in Thessaloniki, Greece from March 15th through 18th. Browse the meeting programme and exhibitors’ list here.